Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Soft Tissue”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05735184
What this trial is testing

Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaMixed Lineage Leukemia Gene MutationRefractory AML+7 more
Kura Oncology, Inc. 420
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Testing effectiveness (Phase 2)Study completedNCT00002185
What this trial is testing

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

Who this might be right for
Sarcoma, KaposiHIV Infections
Agouron Pharmaceuticals 20
Post-approval studies (Phase 4)Active Not RecruitingNCT05610748
What this trial is testing

Implant-supported Rehabilitation With SPAL Technique or Soft Tissue Augmentation

Who this might be right for
DehiscenceAlveolar Ridge EnlargementBone Loss, Alveolar
Università degli Studi di Ferrara 66
Not applicableWithdrawnNCT02507076
What this trial is testing

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Who this might be right for
Basal Cell Carcinoma of the SkinEccrine Carcinoma of the SkinRecurrent Adult Soft Tissue Sarcoma+8 more
Albert Einstein College of Medicine
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Testing effectiveness (Phase 2)Looking for participantsNCT04872543
What this trial is testing

ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors (MPNST)
Memorial Sloan Kettering Cancer Center 25
Early research (Phase 1)Study completedNCT00287885
What this trial is testing

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)Study completedNCT05349643
What this trial is testing

Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Who this might be right for
Pigmented Villonodular SynovitisTGCTTenosynovial Giant Cell Tumor
AmMax Bio, Inc. 20
Large-scale testing (Phase 3)UnknownNCT01483417
What this trial is testing

Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy

Who this might be right for
Uterine MyomaUterine Adenomyosis
Samsung Medical Center 240
Large-scale testing (Phase 3)Active Not RecruitingNCT05417789
What this trial is testing

Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Who this might be right for
TGCT
SynOx Therapeutics Limited 128
Not applicableStudy completedNCT02041689
What this trial is testing

A Qualitative Case Study of the Experiences of Children With Cancer as They Learn About Their Diagnosis and Treatment

Who this might be right for
Sarcoma
St. Jude Children's Research Hospital 4
Early research (Phase 1)UnknownNCT05415098
What this trial is testing

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Who this might be right for
Nasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more
Ascentage Pharma Group Inc. 90
Not applicableStudy completedNCT02104219
What this trial is testing

Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)

Who this might be right for
Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Early research (Phase 1)Ended earlyNCT01804530
What this trial is testing

Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorTumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion MutationsTenosynovial Giant Cell Tumor
Plexxikon 59
Post-approval studies (Phase 4)Study completedNCT02531867
What this trial is testing

Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan

Who this might be right for
Hypophosphatasia
Alexion Pharmaceuticals, Inc. 13
Not applicableLooking for participantsNCT04224064
What this trial is testing

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

Who this might be right for
LiposarcomaAtypical Lipomatous Tumor
Institut du Cancer de Montpellier - Val d'Aurelle 158
Testing effectiveness (Phase 2)Ended earlyNCT04106492
What this trial is testing

Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors

Who this might be right for
Cancer
Shasqi, Inc. 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT05120271
What this trial is testing

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

Who this might be right for
Hepatocellular CarcinomaSquamous Cell Carcinoma of the LungMerkel Cell Carcinoma+1 more
Sotio Biotech Inc. 7
Next Page